ULGX OTC
Urologix, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -97.3%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$14M
-14.2% ▼
5Y CAGR: +2.1%
Gross Profit
$6M
-25.5% ▼
5Y CAGR: -1.1%
Operating Income
-$7M
-76.7% ▼
Net Income
-$8M
-77.3% ▼
EPS (Diluted)
$-0.36
-71.4% ▼
EBITDA
-$6M
-108.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 |
|---|---|---|---|---|---|
| Revenue | $15M | $13M | $17M | $17M | $14M |
| YoY Growth | +15.3% | -14.9% | +35.4% | -2.6% | -14.2% |
| Cost of Revenue | $7M | $6M | $9M | $8M | $8M |
| Gross Profit | $8M | $7M | $8M | $8M | $6M |
| Gross Margin | 55.5% | 52.0% | 49.2% | 49.3% | 42.8% |
| R&D Expenses | $2M | $2M | $2M | $2M | $2M |
| SG&A Expenses | $9M | $8M | $10M | $10M | $8M |
| Operating Expenses | $10M | $10M | $13M | $12M | $10M |
| Operating Income | -$2M | -$4M | -$4M | -$4M | -$7M |
| Operating Margin | -15.3% | -29.6% | -24.3% | -23.6% | -48.7% |
| Interest Expense | $0 | $0 | $482K | $555K | $693K |
| Income Before Tax | -$2M | -$4M | -$5M | -$4M | -$8M |
| Tax Expense | -$88K | $8K | $55K | $14K | -$16K |
| Net Income | -$2M | -$4M | -$5M | -$4M | -$8M |
| Net Margin | -14.7% | -29.7% | -27.6% | -25.9% | -53.4% |
| EPS (Diluted) | $-0.15 | $-0.26 | $-0.32 | $-0.21 | $-0.36 |
| EBITDA | -$1M | -$3M | -$3M | -$3M | -$6M |
| Shares Outstanding | 15M | 15M | 15M | 21M | 21M |